Novel Hepatitis E Vaccine Protects for at Least a Decade

(MedPage Today) -- A three-dose vaccine regimen prevented hepatitis E virus (HEV) infections with high efficacy in adults over the course of 10 years, a phase III trial from China found. The HEV239 vaccine, sold under the name Hecolin outside...
Source: MedPage Today Gastroenterology - Category: Gastroenterology Source Type: news